Trials / Completed
CompletedNCT01825356
Amniotic Membrane as an Adjunct Treatment for Hallux Rigidus
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- OrthoCarolina Research Institute, Inc. · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether patients undergoing a dorsal cheilectomy procedure with implementation of amniotic membrane tissue results in improved clinical and functional outcomes compared to a standard dorsal cheilectomy procedure. Specific Aim 1: To compare American Orthopedic Foot and Ankle Society (AOFAS) scores between patients undergoing dorsal cheilectomy to patients undergoing dorsal cheilectomy with implantation of amniotic membrane tissue. Hypothesis 1: Clinical and functional outcomes, as measured by the AOFAS , in the patients undergoing dorsal cheilectomy with implantation of amniotic membrane tissue will be superior to those without. Specific Aim 2: To compare range of motion between patients undergoing dorsal cheilectomy to patients undergoing dorsal cheilectomy with implantation of amniotic membrane tissue. Hypothesis 2: Patient to undergo dorsal cheilectomy and implantation of amniotic membrane tissue will demonstrate less postoperative stiffness as measured from the pre-and postoperative radiographs. Specific Aim 3: To compare Foot Function Index (FFI) scores between patients undergoing dorsal cheilectomy to patients undergoing dorsal cheilectomy with implantation of amniotic membrane tissue. Hypothesis 3: Clinical and functional outcomes, as measured by the FFI, the patients undergoing dorsal cheilectomy with implantation of amniotic membrane tissue will be superior to those without.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Dorsal Cheilectomy without Amniotic Membrane Tissue Implantation | |
| PROCEDURE | Dorsal Cheilectomy with Amniotic Membrane Tissue Implantation |
Timeline
- Start date
- 2013-04-08
- Primary completion
- 2019-09-01
- Completion
- 2020-11-10
- First posted
- 2013-04-05
- Last updated
- 2023-02-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01825356. Inclusion in this directory is not an endorsement.